TetraLogic Pharmaceuticals Corporation (TLOG) shares surged more than 55 percent on Wednesday after news of positive preliminary data from its ongoing Phase 2A study of birinapant in combination with azacitidine in first line higher risk myelodysplastic syndromes. “While acknowledging the small number of patients involved in the study, we find these data encouraging,” commented Dr. […] View the full post at: Early Movers: TetraLogic (TLOG), ITT Educational Services (ESI), Biocept (BIOC), MBIA (MBI), WPCS Int’l (WPCS) Related posts: ITT Educational Services is Still Undervalued Pimco Says ‘Too Early’ to Buy Greek Bonds as EU Pledges Aid Overnight Market Movers Jan 26, 2010